Generic placeholder image

Mini-Reviews in Organic Chemistry

Editor-in-Chief

ISSN (Print): 1570-193X
ISSN (Online): 1875-6298

Editorial

Application of Multi-component Reactions in the Search of Bioactive Molecules

Author(s): Shujing Xu, Xujie Zhang, Yucen Tao, Xinyong Liu* and Peng Zhan*

Volume 19, Issue 8, 2022

Published on: 22 April, 2022

Page: [894 - 897] Pages: 4

DOI: 10.2174/1570193X19666220224101102

[1]
Younus, H.A.; Al-Rashida, M.; Hameed, A.; Uroos, M.; Salar, U.; Rana, S.; Khan, K.M. Multicomponent reactions (MCR) in medicinal chemistry: A patent review (2010-2020). Expert Opin. Ther. Pat., 2021, 31(3), 267-289.
[http://dx.doi.org/10.1080/13543776.2021.1858797] [PMID: 33275061]
[2]
Kitamura, N.; Sacco, M.D.; Ma, C.; Hu, Y.; Townsend, J.A.; Meng, X.; Zhang, F.; Zhang, X.; Ba, M.; Szeto, T.; Kukuljac, A.; Marty, M.T.; Schultz, D.; Cherry, S.; Xiang, Y.; Chen, Y.; Wang, J. Expedited approach toward the rational design of noncovalent SARS-CoV-2 main protease inhibitors. J. Med. Chem., 2021, acs.jmedchem.1c00509.
[http://dx.doi.org/10.1021/acs.jmedchem.1c00509] [PMID: 33891389]
[3]
Charoenpattarapreeda, J.; Walsh, S.J.; Carroll, J.S.; Spring, D.R. Expeditious total synthesis of hemiasterlin through a convergent multicomponent strategy and its use in targeted cancer therapeutics. Angew. Chem. Int. Ed. Engl., 2020, 59(51), 23045-23050.
[http://dx.doi.org/10.1002/anie.202010090] [PMID: 32894646]
[4]
Krieger, V.; Hamacher, A.; Gertzen, C.G.W.; Senger, J.; Zwinderman, M.R.H.; Marek, M.; Romier, C.; Dekker, F.J.; Kurz, T.; Jung, M.; Gohlke, H.; Kassack, M.U.; Hansen, F.K. Design, multicomponent synthesis, and anticancer activity of a Focused Histone Deacetylase (HDAC) inhibitor library with peptoid-based cap groups. J. Med. Chem., 2017, 60(13), 5493-5506.
[http://dx.doi.org/10.1021/acs.jmedchem.7b00197] [PMID: 28574690]
[5]
Pedrola, M.; Jorba, M.; Jardas, E.; Jardi, F.; Ghashghaei, O.; Viñas, M.; Lavilla, R. Multicomponent reactions upon the known drug trimethoprim as a source of novel antimicrobial agents. Front Chem., 2019, 7, 475.
[http://dx.doi.org/10.3389/fchem.2019.00475] [PMID: 31334221]
[6]
Muthengi, A.; Wimalasena, V.K.; Yosief, H.O.; Bikowitz, M.J.; Sigua, L.H.; Wang, T.; Li, D.; Gaieb, Z.; Dhawan, G.; Liu, S.; Erickson, J.; Amaro, R.E.; Schönbrunn, E.; Qi, J.; Zhang, W. Development of dimethylisoxazole-attached imidazo[1,2-a]pyridines as potent and selective CBP/P300 inhibitors. J. Med. Chem., 2021, 64(9), 5787-5801.
[http://dx.doi.org/10.1021/acs.jmedchem.0c02232] [PMID: 33872011]
[7]
Serafini, M.; Griglio, A.; Aprile, S.; Seiti, F.; Travelli, C.; Pattarino, F.; Grosa, G.; Sorba, G.; Genazzani, A.A.; Gonzalez-Rodriguez, S.; Butron, L.; Devesa, I.; Fernandez-Carvajal, A.; Pirali, T.; Ferrer-Montiel, A. Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) channel softly: The discovery of passerini adducts as a topical treatment for inflammatory skin disorders. J. Med. Chem., 2018, 61(10), 4436-4455.
[http://dx.doi.org/10.1021/acs.jmedchem.8b00109] [PMID: 29722529]
[8]
Nguyen, P.; Doan, P.; Rimpilainen, T.; Konda Mani, S.; Murugesan, A.; Yli-Harja, O.; Candeias, N.R.; Kandhavelu, M. Synthesis and preclinical validation of novel indole derivatives as a GPR17 agonist for glioblastoma treatment. J. Med. Chem., 2021, 64(15), 10908-10918.
[http://dx.doi.org/10.1021/acs.jmedchem.1c00277] [PMID: 34304559]
[9]
Dayal, N.; Řezníčková, E.; Hernandez, D.E.; Peřina, M.; Torregrosa-Allen, S.; Elzey, B.D.; Škerlová, J.; Ajani, H.; Djukic, S.; Vojáčková, V.; Lepšík, M.; Řezáčová, P.; Kryštof, V.; Jorda, R.; Sintim, H.O. 3H-Pyrazolo[4,3-f]quinoline-based kinase inhibitors inhibit the proliferation of acute myeloid leukemia cells in vivo. J. Med. Chem., 2021, 64(15), 10981-10996.
[http://dx.doi.org/10.1021/acs.jmedchem.1c00330] [PMID: 34288692]
[10]
Lammi, C.; Sgrignani, J.; Arnoldi, A.; Lesma, G.; Spatti, C.; Silvani, A.; Grazioso, G. Computationally driven structure optimization, synthesis, and biological evaluation of imidazole-based Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) inhibitors. J. Med. Chem., 2019, 62(13), 6163-6174.
[http://dx.doi.org/10.1021/acs.jmedchem.9b00402] [PMID: 31260298]
[11]
Thomas, J.; Jecic, A.; Vanstreels, E.; van Berckelaer, L.; Romagnoli, R.; Dehaen, W.; Liekens, S.; Balzarini, J. Pronounced anti-proliferative activity and tumor cell selectivity of 5-alkyl-2-amino-3-methylcarboxylate thiophenes. Eur. J. Med. Chem., 2017, 132, 219-235.
[http://dx.doi.org/10.1016/j.ejmech.2017.03.044] [PMID: 28365318]
[12]
Ewies, E.F.; El-Hussieny, M.; El-Sayed, N.F.; Fouad, M.A. Design, synthesis and biological evaluation of novel α-aminophosphonate oxadiazoles via optimized iron triflate catalyzed reaction as apoptotic inducers. Eur. J. Med. Chem., 2019, 180, 310-320.
[http://dx.doi.org/10.1016/j.ejmech.2019.07.029] [PMID: 31323616]
[13]
Sutanto, F.; Shaabani, S.; Neochoritis, C.G.; Zarganes-Tzitzikas, T.; Patil, P.; Ghonchepour, E.; Dömling, A. Multicomponent reaction-derived covalent inhibitor space. Sci. Adv., 2021, 7(6)eabd9307
[http://dx.doi.org/10.1126/sciadv.abd9307] [PMID: 33536213]
[14]
Jiang, X.; Hao, X.; Jing, L.; Wu, G.; Kang, D.; Liu, X.; Zhan, P. Recent applications of click chemistry in drug discovery. Expert Opin. Drug Discov., 2019, 14(8), 779-789.
[http://dx.doi.org/10.1080/17460441.2019.1614910] [PMID: 31094231]
[15]
Wang, X.; Huang, B.; Liu, X.; Zhan, P. Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries. Drug Discov. Today, 2016, 21(1), 118-132.
[http://dx.doi.org/10.1016/j.drudis.2015.08.004] [PMID: 26315392]

© 2024 Bentham Science Publishers | Privacy Policy